Brief: Lupin And Natco Receive U.S. FDA Approval For Bosentan Tablets
10/02/2025 09:31
Feb 10 (Reuters) - Lupin Ltd LUPN.NS :
* LUPIN LTD - CO AND NATCO RECEIVE U.S. FDA APPROVAL FOR
BOSENTAN
TABLETS
Source text: ID:nBSEb28kSJ
Further company coverage: LUPN.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Natco Pharma
See all newsBrief: Natco Pharma Launches Carboplatin Injection In Us With Teyro Labs
India's Natco Pharma jumps after launching ovarian cancer drug in US
Brief: Natco Pharma Announces Launch Of Carboplatin Injection In The U.S. Market
Brief: Natco Pharma To Increase Its Investment In Egenesis To $16.70 Million
Brief: Natco Pharma Approves Rights Issue Up To 12.79 Billion Rupees